Stock profile
Samyang Holdings Corporation logo

Samyang Holdings Corporation(000070.KS)

Country: South KoreaSector: IndustrialsIndustry: ConglomeratesExchange: KSC
P/E TTM
N/A
History
P/E NTM
4.2
Market cap
400.57B
Currency KRW
KvantraRanki45
Value92
Quality15
Momentum12
Current price
59,600.00+0.17%
Benchmarks

No price history available.

Key financial summary

Financials in KRW
202020212022202320242025TTM2026E
Total revenueKRWm2,471,2263,107,3133,316,7783,210,8533,553,2643,348,427N/AN/A
Operating profitKRWmLockedLockedLockedLockedLockedLockedLockedLocked
Net profitKRWm102,313237,70171,009172,36628,270-196,840N/AN/A
EPS reportedKRWLockedLockedLockedLockedLockedLockedLockedLocked
Operating cashflow per shareKRWLockedLockedLockedLockedLockedLockedLockedLocked
Capex per shareKRWLockedLockedLockedLockedLockedLockedLockedLocked
FCF per shareKRWLockedLockedLockedLockedLockedLockedLockedLocked
Free cash flowKRWmLockedLockedLockedLockedLockedLockedLockedLocked
Net debtKRWmLockedLockedLockedLockedLockedLockedLockedLocked
Book value equityKRWmLockedLockedLockedLockedLockedLockedLockedLocked
Book value per shareKRWLockedLockedLockedLockedLockedLockedLockedLocked
Number of sharesmLockedLockedLockedLockedLockedLockedLockedLocked
DPS (TTM paid)KRWLockedLockedLockedLockedLockedLockedLockedLocked

Financial summary

Financials in KRW
202020212022202320242025TTM2026E
Value
P/E LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/B LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/S LTMxLockedLockedLockedLockedLockedLockedLockedLocked
P/FCF LTMxLockedLockedLockedLockedLockedLockedLockedLocked
EV/EBITDA LTMxLockedLockedLockedLockedLockedLockedLockedLocked
EV/Sales LTMxLockedLockedLockedLockedLockedLockedLockedLocked
Earnings Yield LTM%LockedLockedLockedLockedLockedLockedLockedLocked
FCF Yield%LockedLockedLockedLockedLockedLockedLockedLocked
Quality
ROE%LockedLockedLockedLockedLockedLockedLockedLocked
ROIC%LockedLockedLockedLockedLockedLockedLockedLocked
Operating margin%LockedLockedLockedLockedLockedLockedLockedLocked
Gross margin%LockedLockedLockedLockedLockedLockedLockedLocked
FCF/Sales%LockedLockedLockedLockedLockedLockedLockedLocked
Growth and momentum
EPS Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
Sales Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
Net Income Growth YoY%LockedLockedLockedLockedLockedLockedLockedLocked
FCF Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Operating Profit Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Dividend and capital structure
Dividend Yield%LockedLockedLockedLockedLockedLockedLockedLocked
Dividend Growth%LockedLockedLockedLockedLockedLockedLockedLocked
Payout Ratio%LockedLockedLockedLockedLockedLockedLockedLocked
FCF/DebtxLockedLockedLockedLockedLockedLockedLockedLocked
Net Debt/EBITDAxLockedLockedLockedLockedLockedLockedLockedLocked
EBIT/Net interestxLockedLockedLockedLockedLockedLockedLockedLocked
Net debt/market cap%LockedLockedLockedLockedLockedLockedLockedLocked
Net debt/Equity%LockedLockedLockedLockedLockedLockedLockedLocked
Gross debt/equity%LockedLockedLockedLockedLockedLockedLockedLocked

Ratings

Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked
Number of covering analystsLocked

Based on consensus from external analysts. Not Kvantra's opinion.

Company overview

Samyang Holdings Corporation, a diversified conglomerate founded in Seoul, South Korea, in 1924, engages in a wide array of activities through its various subsidiaries. The company's operations span the chemical, food, packaging, pharmaceutical, and IT service sectors. Its chemical division manufactures an extensive range of advanced materials, including value-added chemicals, terephthalic acid, various polycarbonate (PC) resins, bisphenol-A, and specialized engineering plastics. They also produce PC and polybutylene terephthalate compounds, PET bottles, and long fiber reinforced thermoplastics. In the food business, Samyang offers both health and wellness products and starch-based sugars. The company also extends into consumer services, operating the Seven Springs salad and brunch restaurant concept, along with Café Seven Springs bakeries. Its pharmaceutical arm develops and markets anti-cancer treatments such as Genexol and Nanoxel PM, in addition to medical devices like the NicoStop smoking cessation patch and biodegradable surgical sutures, including Trisorb and Monosorb. Samyang's products have a global reach, being exported to over 80 countries. Furthermore, Samyang provides comprehensive IT services, offering consulting for system management and integration, e-business solutions, and enterprise software (ERP, e-HR, MES, and mobile services) to clients in the public, finance, and manufacturing industries.

SectorIndustrials
IndustryConglomerates
CountrySouth Korea
Trades inKRW

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Samyang Holdings Corporation (000070.KS)

000070.KS · KSC · Industrials
59,600.00+0.17%
Sign up to track this stock

No price history available.

KvantraRank45
P/E TTMN/A
P/E NTM4.2
Market cap400.57B
KvantraRank45 / 100
Value
92
Quality
15
Momentum
12
Financialsin KRW
20242025TTM2026E
Ratings
Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked

Based on consensus from external analysts. Not Kvantra's opinion.

About

Samyang Holdings Corporation, a diversified conglomerate founded in Seoul, South Korea, in 1924, engages in a wide array of activities through its various subsidiaries. The company's operations span the chemical, food, packaging, pharmaceutical, and IT service sectors. Its chemical division manufactures an extensive range of advanced materials, including value-added chemicals, terephthalic acid, various polycarbonate (PC) resins, bisphenol-A, and specialized engineering plastics. They also produce PC and polybutylene terephthalate compounds, PET bottles, and long fiber reinforced thermoplastics. In the food business, Samyang offers both health and wellness products and starch-based sugars. The company also extends into consumer services, operating the Seven Springs salad and brunch restaurant concept, along with Café Seven Springs bakeries. Its pharmaceutical arm develops and markets anti-cancer treatments such as Genexol and Nanoxel PM, in addition to medical devices like the NicoStop smoking cessation patch and biodegradable surgical sutures, including Trisorb and Monosorb. Samyang's products have a global reach, being exported to over 80 countries. Furthermore, Samyang provides comprehensive IT services, offering consulting for system management and integration, e-business solutions, and enterprise software (ERP, e-HR, MES, and mobile services) to clients in the public, finance, and manufacturing industries.

SectorIndustrials
IndustryConglomerates
CountrySouth Korea
Trades inKRW

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data for this stock

Unlimited access to every company

See plans

Unlock all fundamental data for this stock

Unlimited access to every company

See plans